Campana, Irene
Minafò, Ylenia Aura
Scaglione, Giovanni Luca
Giovanardi, Giulia
Cosio, Terenzio
Lanna, Caterina
Artosi, Fabio
Lambiase, Sara
Valente, Carola
Bartolocci, Valeria
Morelli, Martina
Albanesi, Cristina
Palese, Enzo
Minieri, Marilena
Giovannelli, Alfredo
Avitabile, Daniele
Salcedo, Nidia Margot
Mastroeni, Simona
Mazzanti, Cinzia
Abeni, Damiano
Campione, Elena
Fania, Luca
Dellambra, Elena https://orcid.org/0000-0002-4329-3312
Funding for this research was provided by:
Ministero della Salute (Ricerca Corrente RC2020-23)
Ministero della Salute (RF2016-02362541)
Idi Farmaceutici s.r.l
European Union Next Generation EU–PNRR M6C2–Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN (PNRR-MCNT2-2023-12378474)
Article History
Received: 5 February 2026
Accepted: 17 March 2026
First Online: 11 April 2026
Declarations
:
: Irene Campana, Ylenia Aura Minafò, Giovanni Luca Scaglione, Giulia Giovanardi, Terenzio Cosio, Caterina Lanna, Fabio Artosi, Sara Lambiase, Carola Valente, Valeria Bartolocci, Martina Morelli, Cristina Albanesi, Enzo Palese, Marilena Minieri, Alfredo Giovannelli, Daniele Avitabile, Nidia Margot Salcedo, Simona Mastroeni, Cinzia Mazzanti, Damiano Abeni, Elena Campione, Luca Fania, and Elena Dellambra have nothing to disclose.
: The clinical study protocol was approved by the local ethics committee at IDI–IRCCS, Rome, Italy, and the study (protocol no. 518-2/19-12-2019) was executed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from each participant before inclusion in the study.